Is Telefônica Brasil a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Telefônica Brasil in the last year. There are currently 2 hold ra...
How has Telefônica Brasil's stock price been impacted by COVID-19?
Telefônica Brasil's stock was trading at $11.37 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organizatio...
When is Telefônica Brasil's next earnings date?
Telefônica Brasil is scheduled to release its next quarterly earnings announcement on Wednesday, May 11th 2022. View our earnings forecast for Tel...
How were Telefônica Brasil's earnings last quarter?
Telefônica Brasil S.A. (NYSE:VIV) posted its quarterly earnings results on Tuesday, February, 22nd. The Wireless communications provider reported $...
How often does Telefônica Brasil pay dividends? What is the dividend yield for Telefônica Brasil?
Telefônica Brasil declared a dividend on Thursday, February 17th. Shareholders of record on Thursday, March 3rd will be paid a dividend of $0.018 p...
Is Telefônica Brasil a good dividend stock?
Telefônica Brasil pays an annual dividend of $0.33 per share and currently has a dividend yield of 3.19%. The dividend payout ratio of Telefônica B...
What price target have analysts set for VIV?
2 brokerages have issued 1 year price objectives for Telefônica Brasil's shares. Their forecasts range from $9.00 to $9.00. On average, they expect...
Who are Telefônica Brasil's key executives?
Telefônica Brasil's management team includes the following people: Mr. Christian Mauad Gebara , CEO & Director (Age 48) Mr. David Melcon Sanchez...
What is Antonio Carlos Valente da Silva's approval rating as Telefônica Brasil's CEO?
30 employees have rated Telefônica Brasil CEO Antonio Carlos Valente da Silva on Glassdoor.com . Antonio Carlos Valente da Silva has an approval r...
About VIV
Financial Performance
Telefônica Brasil S.A., together with its subsidiaries, provides mobile and fixed telecommunications services to residential and corporate customers in Brazil.
Analyst Forecast
In 2020, VIV's revenue was 43.13 billion, a decrease of -2.58% compared to the previous year's 44.27 billion. Earnings were 4.77 billion, a decrease of -4.61%.
News
According to 8 analysts, the average rating for VIV stock is "Buy." The 12-month stock price forecast is 11.59, which is an increase of 37.29% from the latest price.
Recently Viewed Tickers
SÃO PAULO, July 27, 2021 /PRNewswire/ -- Telefônica Brasil - (B3: VIVT3; NYSE: VIV), announces its results for 2Q21. Revenue acceleration driven by positive evolution of mobile and fiber accesses, comb...
Telefonica Brasil S.A. ADR
Visit a quote page and your recently viewed tickers will be displayed here.
VIV Depositary Receipt Chart
Telefonica Brasil SA engages in the provision of telecommunication services. It offers post paid mobile and fixed telecommunications services, such as fixed and mobile voice, fixed, mobile broadband and ultra broadband. The company was founded in May 1998 and is headquartered in São Paulo, Brazil.
Ideas
the EURONEXT:VIV stock's is technically overvalued. You can take advantage of a correction to take position.
Who bought Universal Music Group?
the EURONEXT:VIV stock's is technically overvalued. You can take advantage of a correction to take position.
Is vivendi a spin off?
Billionaire hedge fund manager William Ackman on Tuesday bought 7.1% of Universal Music Group from French conglomerate Vivendi and pledged to keep buying after his original plan to acquire a 10% stake in the record label for his blank-check company collapsed.
Is Mediaset a cross-border company?
French media group Vivendi will seek investor support on Tuesday to spin off its prized Universal music business, a plan criticized by activist funds for benefiting top shareholder Vincent Bollore more than smaller investors. The world's biggest music label, home to pop stars such as Lady Gaga and Taylor Swift, is valued at 33 billion euros ($39 billion) by Vivendi, or more than the group's own market value. While the spin-off looks set to clear a first hurdle with backing at the June 22 shareholder meeting, a backlash is brewing over the transaction's structure and Vivendi's secretive governance.
What stocks does MarketBeat like better than Avivagen?
Italian broadcaster Mediaset has multiple options to kick off cross-border deals and is currently in talks with potential partners interested in its European TV industry consolidation strategy, its chief executive said on Thursday. Italy's top commercial broadcaster is ready to press on with its long-delayed plans to expand overseas to fend off rising competition from streaming services like Netflix Inc after reaching a truce agreement with its second-largest investor, Vivendi. In an online briefing with journalists on Thursday, Mediaset Chief Executive Pier Silvio Berlusconi said the company aims to create a media factory as part of the European TV project.
How has Avivagen's stock price been impacted by COVID-19?
Wall Street analysts have given Avivagen a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Avivagen wasn't one of them.
Who are some of Avivagen's key competitors?
Avivagen's stock was trading at C$0.60 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VIV stock has decreased by 34.2% and is now trading at C$0.40.#N#View which stocks have been most impacted by COVID-19.
What other stocks do shareholders of Avivagen own?
Some companies that are related to Avivagen include N4 Pharma (N4P), Cathay International Holdings Limited (CTI.L) (CTI), Antisense Therapeutics (ANP), Bayer Aktiengesellschaft (BAYN), Mayne Pharma Group (MAYNF), Mayne Pharma Group (MYX), Medical Developments International (MVP), Opthea (OPT), Otsuka (OTSKY), Patrys (PAB), Pharmaxis (PXS), Recce Pharmaceuticals (RCE), Roche (RHHVF), Sanofi (SNYNF) and Sanofi (SAN).#N#View all of VIV's competitors..
What is Avivagen's stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include (ATE), Astrotech (ASTC), Arcturus Therapeutics (ARCT), (AQB), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), The AES (AES) and AbbVie (ABBV).
How do I buy shares of Avivagen?
Avivagen trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VIV."
What is Avivagen's stock price today?
Shares of VIV and other Canadian stocks can be purchased through an online brokerage account.
Signals & Forecast
One share of VIV stock can currently be purchased for approximately C$0.40.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, July 01, 2021, and so far it has risen 1.82%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning.
Is Telefonica Brasil SA stock A Buy?
On the downside, the stock finds support just below today's level from accumulated volume at $7.92 and $7.89. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Telefonica Brasil SA finds support just below today's level at $7.92.
